GenBioPro, the nation’s only generic manufacturer of the abortion pill mifepristone, appealed the dismissal of a federal lawsuit challenging a West Virginia abortion ban that restricts access to the FDA-approved abortion medication mifepristone.

If successful, GenBioPro’s lawsuit could prevent states from banning mifepristone and could also protect access to other FDA-approved medications that have significant health benefits, such as vaccines.

The West Virginia court’s ruling could be helpful to people in states that still allow some abortions but block telemedicine abortion, such as Arizona, Florida, Georgia, Iowa, Kansas, Montana, Nebraska, Nevada, North Carolina, Ohio, Pennsylvania, South Carolina, Utah and Wisconsin.